Market Highlights

• Acorn, a biotechnology company based in Toronto, has raised $8.1 million to enhance access to regenerative medicine through cell preservation.
• The Ontario government is investing $40.0 million to support the growth and innovation of life sciences companies and biomanufacturers, enabling them to develop life-saving medicines and technologies and compete globally.
• Sanofi celebrated the opening of its cutting-edge 200,000 square foot (sf) biomanufacturing facility, the largest of its kind in Canada, which will be dedicated to producing vaccines for whooping cough, diphtheria, and tetanus.

Read the full report